JP2025506248A5 - - Google Patents

Info

Publication number
JP2025506248A5
JP2025506248A5 JP2024548730A JP2024548730A JP2025506248A5 JP 2025506248 A5 JP2025506248 A5 JP 2025506248A5 JP 2024548730 A JP2024548730 A JP 2024548730A JP 2024548730 A JP2024548730 A JP 2024548730A JP 2025506248 A5 JP2025506248 A5 JP 2025506248A5
Authority
JP
Japan
Application number
JP2024548730A
Other languages
Japanese (ja)
Other versions
JPWO2023155925A5 (https=
JP2025506248A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/077493 external-priority patent/WO2023155925A1/en
Publication of JP2025506248A publication Critical patent/JP2025506248A/ja
Publication of JPWO2023155925A5 publication Critical patent/JPWO2023155925A5/ja
Publication of JP2025506248A5 publication Critical patent/JP2025506248A5/ja
Pending legal-status Critical Current

Links

JP2024548730A 2022-02-21 2023-02-21 抗5t4抗体およびその使用 Pending JP2025506248A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2022077113 2022-02-21
CNPCT/CN2022/077113 2022-02-21
PCT/CN2023/077493 WO2023155925A1 (en) 2022-02-21 2023-02-21 Anti-5t4 antibodies and uses thereof

Publications (3)

Publication Number Publication Date
JP2025506248A JP2025506248A (ja) 2025-03-07
JPWO2023155925A5 JPWO2023155925A5 (https=) 2026-01-22
JP2025506248A5 true JP2025506248A5 (https=) 2026-01-22

Family

ID=87577641

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024548730A Pending JP2025506248A (ja) 2022-02-21 2023-02-21 抗5t4抗体およびその使用

Country Status (8)

Country Link
US (1) US20250154277A1 (https=)
EP (1) EP4482876A1 (https=)
JP (1) JP2025506248A (https=)
KR (2) KR20260033116A (https=)
CN (1) CN118946590A (https=)
AU (2) AU2023220523A1 (https=)
CA (1) CA3250452A1 (https=)
WO (1) WO2023155925A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20260008868A1 (en) * 2024-07-05 2026-01-08 Solve Therapeutics, Inc. 5t4-binding proteins
CN119192356B (zh) * 2024-09-29 2025-05-27 华中农业大学 识别犬瘟热病毒h蛋白的单克隆抗体、检测试纸条及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20100251A1 (es) * 2004-09-10 2010-04-10 Wyeth Corp Anticuerpos anti-5t4 humanizados y conjugados anticuerpo anti-5t4/calicheamicina
MY148763A (en) * 2006-03-10 2013-05-31 Wyeth Corp Anti-5t4 antibodies and uses thereof
DK2694111T3 (en) * 2011-04-01 2016-10-10 Wyeth Llc Antibody pharmaceutical conjugates
WO2014137931A1 (en) * 2013-03-06 2014-09-12 Imaginab, Inc. Antigen binding constructs to 5t4
BR112018010394A8 (pt) * 2015-11-24 2019-02-26 Synthon Biopharmaceuticals Bv anticorpo, conjugado anticorpo-fármaco, composição farmacêutica, e, combinação do anticorpo.
CN108285487B (zh) * 2017-01-08 2021-02-19 浙江昭华生物医药有限公司 抗5t4抗体-药物偶联物及其应用

Similar Documents

Publication Publication Date Title
JP2025506248A5 (https=)
CL2025003573A1 (es) Sistemas y métodos para la extracción de litio a partir de materias primas acuosas
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY23963C1 (https=)
BY13169U (https=)
CN307049508S (https=)
CN307049434S (https=)
CN307049123S (https=)
CN307047600S (https=)
CN307047270S (https=)
CN307046488S (https=)
CN307045528S (https=)
CN307045414S (https=)
CN307044867S (https=)
CN307044452S (https=)
CN307044293S (https=)
BY13140U (https=)
BY23979C1 (https=)
CN307049857S (https=)